STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. The document, which the FDA released Thursday, is the ...
Dublin, Oct. 26, 2021 (GLOBE NEWSWIRE) -- The "Biocompatibility Testing Services for Medical Devices Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been ...
Learn why cytotoxicity test failures are common in medical devices and discover systematic approaches to identify root causes ...
Image of an in vitro irritation test courtesy Nelson Laboratories. Biocompatibility testing requirements for medical devices are changing. "A lot of things are happening, on all fronts," Thor Rollins, ...
Cellulose dermal filler achieves critical biocompatibility milestones, paving the way for clinical trials OTTAWA, ON, April 29, 2025 /CNW/ - Spiderwort Biotechnologies Inc., a pioneering biotechnology ...
(Nanowerk Spotlight) Any drug intended for systemic administration and all medical devices which will contact blood (e.g. oxygenators, tubing, catheters, artificial hearts) must undergo thorough ...
NEW YORK, NY, UNITED STATES, January 26, 2026 /EINPresswire.com/ — STEMart, a US-based provider of comprehensive services for all phases of medical device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results